A.   Increased urine specific gravity

B.   Increased serum albumin levels

C.   Decreased adrenocorticotropic hormone levels

D.   Relief of pain

A.   Adrenocorticotropic hormone (ACTH), Aldosterone, Thyrotropin-releasing hormone (TRH)

B.   Thyroxine, Thyroid-stimulating hormone (TSH), Thyrotropin-releasing hormone (TRH)

C.   Growth hormone (GH), Thyroid-stimulating hormone (TSH), Adrenocorticotropic hormone (ACTH)

D.   Thyroxine, Aldosterone, Thyrotropin-releasing hormone (TRH)

A.   Somatostatin

B.   Somatolactin

C.   Choriomammotropin

D.   Somatropin

A.   Oxytocin

B.   Cosyntropin

C.   Vasopressin

D.   Octreotide

A.   Hypopituitary dwarfism

B.   Polydipsia

C.   Polyuria

D.   Acromegaly

A.   Vasopressin

B.   Desmopressin

C.   Luteinizing hormone

D.   Somatropin

A.   Complete blood count result

B.   Uric acid level

C.   Creatinine clearance test

D.   Blood glucose level

A.   Cyclosporine

B.   Carbamazepine

C.   Ciprofloxacin

D.   Demeclocycline

A.   Cosyntropin

B.   Thyroid hormone

C.   Octreotide

D.   Oxytocin

A.   Polyuria

B.   Dehydration

C.   Headache

D.   Polydipsia

A.   Cosyntropin

B.   Somatropin

C.   Desmopressin

D.   Octreotide

A.   Vasopressin

B.   Octreotide

C.   Somatropin

D.   Desmopressin

A.   Causes prolongation of QT interval

B.   Enhances the effects of desmopressin

C.   Reduces the effects of desmopressin

D.   Produces an additive effect

A.   Scar formation

B.   Hypotension

C.   Inflammation

D.   Edema

A.   Malaise, Dyspnea,

B.   Constipation, Malaise, Hypercalciuria

C.   Arthralgia, Hypercalciuria, Constipation

D.   Dyspnea, Constipation, Hypercalciuria

A.   Liver enzyme levels, Blood glucose levels, Renal function studies

B.   Renal function studies, Liver enzyme levels, Blood pressure

C.   Liver enzyme levels, Renal function studies, Weight

D.   Weight, Blood pressure, Blood glucose levels

A.   Acetaminophen

B.   Thioridazine

C.   Carbamazepine

D.   Norepinephrine

A.   Improved tissue-building processes, Low blood sugar levels, Retention of potassium levels

B.   Low blood sugar levels, Retention of potassium levels, Increased retention of sodium

C.   Increased lipid mobilization, Increased retention of sodium, Improved tissue-building processes

D.   Low blood sugar levels, Increased lipid mobilization, Retention of potassium levels

A.   Decreases growth

B.   Reduces fat levels

C.   Reduces weight loss

D.   Decreases fluid retention

A.   Diabetes insipidus, Seizure, Type I von Willebrand

B.   Asthma, Diabetes insipidus, Type I von Willebrand

C.   Seizure, Asthma, Cardiovascular disease

D.   Cardiovascular disease, Diabetes insipidus, Type I von Willebrand

A.   Fludrocortisone

B.   Cyclosporine

C.   Glucocorticoids

D.   Ciprofloxacin

A.   Hypokalemia

B.   Hyperglycemia

C.   Hyponatremia

D.   Orthostatic hypotension

A.   Edema

B.   Seizures

C.   Heartburn

D.   Hypoglycemia

A.   Vasopressin and carbamazepine

B.   Vasopressin and demeclocycline

C.   Desmopressin and carbamazepine

D.   Somatropin and glucocorticoids

A.   A 17-year-old who is 5 feet tall

B.   An 8-year-old with a pituitary tumor

C.   A 7-year-old diagnosed with growth hormone deficiency

D.   A 10-year-old of short stature who has severe asthma

A.   Acute bronchitis with laryngitis

B.   Human immunodeficiency virus (HIV) infection

C.   Cachexia and closed growth plates

D.   Bilateral metastatic breast cancer

A.   Oozing blood

B.   Loss of consciousness

C.   Abundant, diluted urine

D.   Watery diarrhea

A.   "Apply the drug preparation topically to the nasal membranes."

B.   "Inhale the drug preparation by spraying into the nostrils."

C.   "Dilute the drug preparation before administration."

D.   "Shake the drug preparation thoroughly before use."

A.   Hypercalciuria

B.   Hyperglycemia

C.   Hypertension

D.   Hypothyroidism

A.   Pressing the pump once to spray a 10-mcg dose

B.   Pressing down on the pump two times to prime it

C.   Replacing the cap on the pump after the procedure

D.   Priming the nasal pump once a week

A.   Motor skills, Visual acuity, Skin turgor

B.   Weight, Skin turgor, Visual acuity

C.   Height, Weight, Motor skills

D.   Skin turgor, Height, Visual acuity

A.   "Do you feel very thirsty lately?" "How many times do you urinate in a day?"

B.   "Do you have excessive bleeding due to minor injuries?" "Is there any change in the color of your urine?"

C.   "Is there any change in the color of your sputum?" "Do you have excessive bleeding due to minor injuries?"

D.   "Is there any change in the color of your urine?" "Is there any change in the color of your sputum?"

A.   Administering half the dose in each nostril

B.   Priming the pump each week

C.   Storing the pump at room temperature

D.   Inhaling the medication into the airway

A.   A higher dose of medication is required for treatment.

B.   The patient is stable and needs reassurance.

C.   The patient needs to adjust fluid intake.

D.   The medication is not effective for this condition.

A.   Diarrhea, Flushing

B.   Headache, Joint pain

C.   Fatigue, Headache

D.   Joint pain, Fatigue

A.   Patient D: VIP; severe diarrhea and flushing; renal impairment

B.   Patient C: VIP; life-threatening hypotension; diarrhea and flushing

C.   Patient B: carcinoid tumor; taking ciprofloxacin

D.   Patient A: esophageal varices; type 1 diabetes

A.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Replace the cap on the bottle. 5. Give half a spray in each nostril. 6. Monitor the level of drug left in the pump.

B.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

C.   1. Clear the nasal passages. 2. Give half a spray in each nostril. 3. Place the spray nozzle in the nostril. 4. Prime the pump by pressing down four times. 5. Replace the cap on the bottle. 6. Monitor the level of drug left in the pump.

D.   1. Clear the nasal passages. 2. Prime the pump by pressing down four times. 3. Place the spray nozzle in the nostril. 4. Give half a spray in each nostril. 5. Monitor the level of drug left in the pump. 6. Replace the cap on the bottle.

A.   Small-bowel fistula and having an acute asthma attack

B.   Acromegaly and a serum creatinine level of 5.0 mg/dL

C.   Carcinoid tumor-secreting vasoactive intestinal peptide (VIP)

D.   Esophageal varices and a history of type 2 diabetes

A.   Watch the IV site closely for infiltration.

B.   Assess for signs of dehydration.

C.   Measure the patient’s urine output regularly.

D.   Make a note of the fluid intake.

A.   Edema of the extremities, Elevated blood pressure

B.   Increased urination, Thirst

C.   Weight gain, Edema of the extremities

D.   Elevated blood pressure, Weight gain

A.   Assess the patient for headaches

B.   Notice increase in body temperature

C.   Inquire about abdominal discomfort

D.   Monitor for signs of infiltration

A.   Calculate the dosage with the pharmacist or another nurse

B.   Review the frequency with the health care provider

C.   Obtain baseline weight and height measurements

D.   Review current laboratory values for blood glucose

A.   Reports episodic muscle pain during the past year.

B.   Previous somatropin injection site tender to touch.

C.   Radiology report identifies no fracture with closed growth plates.

D.   Growth percentile has increased from the previous annual physical.

A.   Electrocardiogram (ECG)

B.   Blood glucose

C.   Renal panel

D.   Liver enzymes

A.   Vasopressin nasal spray

B.   Desmopressin intravenously

C.   Somatropin intramuscular

D.   Octreotide subcutaneous

A.   Nausea, Blood glucose elevation, Headache, Low urine output

B.   Headache, Low urine output, Low blood pressure, Nausea

C.   Low blood pressure, Blood glucose elevation, Headache, Low urine output

D.   Nausea, Blood glucose elevation, Headache, Low blood pressure

A.   Bleeding gums

B.   Limping

C.   Abdominal cramps

D.   Excessive thirst

A.   Monitoring the patient in an intensive care unit

B.   Obtaining liver and renal function tests

C.   Co-administering carbamazepine

D.   Administering the vasopressin intravenously

A.   Monitor fluid status.

B.   Encourage vigorous exercise.

C.   Evaluate the patient for limping.

D.   Monitor blood glucose levels closely.

A.   "Heat the medicine before administration."

B.   "Keep the bottle in warm water before administration."

C.   "Do not administer the drug to the patient."

D.   "Shake the medication before administration."

A.   Vertigo

B.   Abdominal stress

C.   Bleeding gums

D.   Drowsiness

A.   Somatropin

B.   Cosyntropin

C.   Desmopressin

D.   Vasopressin

A.   "If it is almost time for your next dose, take a double dose of the drug at that time."

B.   "You should consult your primary health care provider immediately."

C.   "You can take the dose immediately when you remember it."

D.   "Skip the missed dose and resume your usual dosage schedule."

A.   Desmopressin

B.   Vasopressin

C.   Octreotide

D.   Somatropin

A.   Desmopressin

B.   Octreotide

C.   Somatropin

D.   Corticotropin